The mechanism of arsine (AsH 3 ) toxicity is not completely understood. In this investigation, we determined AsH 3 and arsenite (AsIII) toxicity in Sprague Dawley rat blood, liver, and kidney. In all systems, there were dose-and time-dependent responses. Red blood cells were very susceptible to AsH 3 toxicity. This was demonstrated by an immediate intracellular potassium loss and by hemolysis and lactate dehydrogenase (LDH) leakage that occurred by one h. AsIII concentrations up to 1 mM were not toxic to red blood cells using these indicators. Both AsH 3 and AsIII produced toxicity in primary hepatocytes. Both produced significant LDH leakage and decreases in intracellular K ؉ by 5 h, but AsIII was more toxic than AsH 3 . At 24 h, both arsenic species showed similar toxicity. In renal cortical epithelial cells, AsH 3 produced no effects on LDH and K ؉ over a 5-h period but produced significant LDH leakage by 24 h. In these cells, AsIII produced significant toxicity as early as in 3 h. These results showed that unchanged AsH 3 produced toxicity in tissues, in addition to blood, and that toxicity of arsenicals is arsenic species-and tissue-dependent.
Dodge, IA), 5 mg/ml xylazine (Rompun, Miles Inc., Shawnee Mission, KS), and 2.5 mg/ml acepromazine (acepromazine maleate, Fermenta Animal Health Co., Kansas City, MO). Strong cation exchange resin (AG 50W-ϫ8, 100 -200 mesh, hydrogen form) and strong anion exchange resin (Dowex 1-1X2, 50 -100 mesh, chloride form) were purchased from Bio-Rad Laboratories (Richmond, CA). All other chemicals were purchased from Sigma Chemical Co. (St. Louis, MO).
Animals. Male Sprague Dawley rats (SD) (200 -250 g) were purchased from Harlan Sprague Dawley, Inc (Indianapolis, IN) and acclimated for 7 days prior to use. Rats were randomly allocated to groups (n ϭ 3) such that the group means and standard deviations in body weight were approximately equal. A standard laboratory diet and water were provided to all animals ad libitum. A 12-h on/12-h off light cycle was maintained in the animal room. The temperature and relative humidity were maintained at 22°C and ϳ40%, respectively.
Arsine generation. AsH 3 was generated by the method of Hatlelid et al. (1995) . Briefly, zinc arsenide was reacted with 50% sulfuric acid to generate the AsH 3 gas which was bubbled into PBS (erythrocytes experiment) or serum-free dosing medium (liver or renal cells) to the desired concentration. AsH 3 concentration in PBS or medium was determined by reaction with 0.55% diethyldithiocarbamate in pyridine followed by spectrophotometric determination of this product at 510 nm. Caution: AsH 3 is a toxic gas and appropriate precautions should be taken. All procedures should be performed in an approved fume hood. A saturated potassium permanganate solution trap, in-line after the aqueous trap, should be used to prevent the release of AsH 3 during its generation.
Collection and incubation of rat blood. Adult male Sprague-Dawley rats were anesthetized with KRA. Blood was drawn by cardiac puncture, and heparin was used as the anticoagulant. Isolated red blood cells were prepared by centrifugation at 900 ϫ g for 10 min. The plasma and buffy coat were removed and the cells were rinsed twice with PBS (containing glucose). Packed erythrocytes were mixed 1:1 with 1mM AsH 3 or PBS for control in closed 1.5-ml microcentrifuge tubes. Erythrocyte incubations were perfomed in a Lab-Line Orbit Environ-Shaker model 3527GM set at 37°C and 100 rpm (Lab-Line Instruments Inc., Melrose Park, IL).
Isolation and dosing of rat hepatocytes and renal cells. Primary hepatocytes were isolated using the method outlined by McQueen (1989) . Hepatocytes were plated in T-25 flasks at a density of 2 ϫ 10 6 /flask in Williams Medium E containing 10% FBS and 50 g/l gentamicin. Cells were allowed to attach for 2 h, then the medium was removed and fresh serum medium (Williams Medium E ϩ 10% FBS ϩ 50 g/l gentamicin) was added. Cells were allowed to completely recover from isolation for 24 h prior to exposure. Renal cortical epithelial cells were isolated by collagenase Type II digestion. Male Sprague-Dawley rats were anesthetized with KRA. Kidneys were pefused in situ through the abdominal aorta with ice-cold Krebs-Henseleit buffer (KHB) (NaCl, 118 mM; KCl, 4 mM; KH 2 PO 4 , 1 mM; NaHCO 3 , 27.2 mM; MgCl 2 , 1.25 mM; Glucose, 5 mM; and HEPES, 10 mM; pH 7.4) previously gassed for 30 min with 95%O 2 /5%CO 2 . Perfusion was performed for 5 min at 30 ml/min. After perfusion, the kidneys were removed and placed in a cold petri dish, decapsulated, cut in 4 pieces each, and the medullas carefully dissected out. The resultant chips of kidney cortex were further cut in 1-mm pieces and placed in 20 ml of the enzymatic solution (270 units/ml of collagenase Type II, 50 g/ml gentamicin, and 50 g/ml trypsin inhibitor). The tissue was digested in 5 periods of 20 min each at 37°C, with moderate shaking. After each period, the digestive solution was replaced by fresh enzymatic solution, the digestive solution containing cells was centrifuged at 228 g for 10 min, and the pellet was resuspended in 5 ml of DMEM/F-12 (5% FBS, 50 g/ml gentamicin) and kept at 37°C until the end of the cell-isolation procedure. After the last period, all cells (from previous periods) were joined in a 50-ml centrifuge tube, and centrifuged one more time. The pellet was now resuspended in a red-blood-cell lysing solution (0.1 mM EDTA, 1 mM KHCO 3 , 170 mM NH 4 Cl, pH 7.3), gently mixed, and incubated for 5 min at room temperature. Then cells were centrifuged again and the pellet was washed 3ϫ with serum-containing medium. The clean cell pellet was resuspended in 40 ml of medium and distributed in 10 T-25 flasks (4 ml/flask) previously coated with rat tail collagen. After plating, the cells were allowed to attach for 18 h, then medium was removed and fresh serum medium was added. Medium was changed every other day for a week to allow cell growth. A week later the renal cells were dosed. All cells were kept in a humidified incubator (Model 6300, NAPCO, Portland, OR) at 37°C and 5% CO 2 .
Prior to exposure to the arsenicals, the attached cells were adapted to serum-free medium, 2 ml per flask, for 2 h (Williams medium E for hepatocytes and DMEM/F-12 for renal cells). Then, this medium was removed and the cells were dosed with the arsenicals prepared in the serum-free medium at the desired concentration. Cell incubations were performed at 37°C and 95:5% O 2 /CO 2 with saturated humidity in the incubator described above. AsH 3 -dosed flasks were kept closed for 4 h and then caps were loosened to allow gas exchange.
Measurement of hemolysis.
Hemoglobin leakage into the extracellular fluid was considered a direct measure of total erythrocyte death or hemolysis. It was determined as described by Winski et al. 1997 .
Determination of intracellular K ϩ in RBC was made as described by Winski et al. 1997 . Intracellular K ϩ in liver and kidney cells was determined in cell lysate supernatant. After incubations, the dosing medium was removed and the flasks containing cells were gently rinsed twice with 2 ml Tris-HCl buffer (pH 7.4). After the last wash, the cells were carefully scraped in 1 ml of buffer and then transferred to 1.5 ml microcentrifuge tubes where they were sonicated for 4 s (power level 4) (4710 Series Ultrasonic homogenizer, Cole-Parmer Instrument Co., Chicago, Ill) to make cell lysate. Proteins were precipitated by the addition of 20 l of concentrated perchloric acid (70%) followed by centrifugation at 16,000 ϫ g for 10 min. Intracellular K ϩ in the resulting supernatant was determined by flame photometry (Coleman Model 51Ca, Bacharach Inc., Pittsburg, PA).
LDH release. The dosing medium, removed after incubations, was saved and kept at 4°C. LDH activity was determined in both the cell lysate prepared as described above and the dosing medium, using an LD-L Kit (Sigma Chemical Co., St. Louis, MO). Determination is based on the rate of increase in absorbance at 340 nm that occurs as LDH oxidizes lactate and reduces NAD ϩ . LDH determination was performed within 2 h. The results are expressed as percent of total LDH activity calculated as follows: LDH activity in medium (leakage) divided by the sum of LDH activity in medium and LDH activity in cell lysate.
Arsine oxidation by the tissue homogenates. Male SD rats were anesthetized as described earlier. The liver and kidney were perfused in situ with PBS through the abdominal aorta. Tissues were removed intact, weighed, and diced. Tissues were then homogenized in 4ϫ w/v of PBS using 6 passes with a teflon glass homogenizer to make 20% (w/v) homogenate. Tissue homogenates were first incubated with 100 M periodate oxidized adenosine (PAD) for 10 min at 37°C and then with 1 mM S-adenosyl-homocysteine (SAH) to inhibit arsenic methylation. Then homogenates were dosed 1:1 with 2 mM AsH 3 for 5, 10, 30, and 60 min. With methylation inhibited, only AsIII and As(V) were present. These arsenic species were separated using anion exchange chromatography as described by Winski and Carter (1995) . Briefly, each sample was centrifuged at 16,000 ϫ g for 1 min to remove insoluble material, and an aliquot from the supernatant was removed and quantified for AsH 3 remaining in the incubation reaction. The remaining supernatant was loaded on the column and pellets were washed 3ϫ with cold PBS, centrifuged, and supernatants loaded on the same column. After loading the samples, AsIII was eluted with 7 ml water. As(V) remained bound to the resin and was later eluted with 7 ml 0.5N HCl. Arsenicals were determined by hydride generation coupled to spectroscopy, as described by Winski and Carter (1995) .
Data analysis.
Individual experiments were performed at least in duplicate, and sample number (n) refers to the number of at least 3 separate experiments. All data are expressed as the mean Ϯ standard deviation. Values are denoted with one asterisk (*) or two asterisks (**) if statistically different from controls at p Ͻ 0.05 or p Ͻ 0.01, respectively, using one-way analysis of variance (ANOVA) with Dunnett's multiple comparison test (GraphPad Prism, GraphPad Software, Inc., San Diego, CA). Statistical differences between treatment groups were calculated using ANOVA with Bonferroni's multiple comparison test (GraphPad Prism, GraphPad Software, Inc., San Diego, CA).
RESULTS

Red Blood Cells (RBC)
Intracellular K ϩ leakage is used as an early sign of toxicity, and it indicates loss of cellular control over ion fluxes. LDH release only occurs when cells have ruptured and is indicative of cell death. Rat erythrocytes exposed to 0.5 mM AsH 3 or AsIII exhibited differential toxicity. A total of 40% of K ϩ was lost immediately after AsH 3 exposure, and by 5 min this reached 65%. From 15 min-to 1-h exposures, K ϩ content was kept fairly constant at 25-30% of control (Fig. 1A) . Erythrocytes exposed to 0.5mM AsIII did not show K ϩ loss over one h incubation. Hemolysis, measured as percent of total hemoglobin release, resembled LDH leakage. With AsH 3 exposure, both reached 40% after 30-min incubation. At 1-h incubation, hemolysis reached 70% and LDH 68%. From 1 to 2 h, hemolysis was kept constant (70%), whereas LDH release further increased to 80% of total LDH (Figs. 1B and 1C). Neither hemolysis nor LDH leakage was affected by 0.5 mM AsIII over 2 h of incubation. These data together indicate that AsH 3 is toxic to rat erythrocytes, whereas AsIII is not. According to K ϩ data, AsH 3 seemed to affect a K ϩ transporter that then failed to control intracellular K ϩ levels. Data from hemolysis and LDH release suggested that cell membrane integrity was affected later and followed K ϩ leakage.
Primary Hepatocytes
Primary hepatocytes were affected by both arsenical compounds. Hepatocytes incubated with 1 mM AsH 3 or AsIII for 1, 3, and 5 h showed a time-dependent increase in percent of total LDH release and decrease in intracellular K ϩ . A concentration of 1 mM AsH 3 produced 14, 28, and 47% release of total LDH and decreased intracellular K ϩ by 3, 18, and 48% at 1, 3, and 5 h, respectively. Likewise, 1 mM AsIII produced 12, 66, and 89% release of total LDH and decreased intracellular K ϩ by 14, 50, and 79% at 1, 3, and 5 h, respectively (Figs. 2A and 2B). Incubations with both arsenicals up to 5 h produced toxic effects on both parameters with AsIII being the most toxic species (Figs. 2A and 2B ). These hepatocytes, dosed with various arsenical concentrations (1-1000 M) for 24 h, showed dose-dependent toxic effects. At 24 h, AsH 3 concentrations above 10 M produced a significant decrease in intracellular K ϩ , whereas AsIII concentrations above 100 M were required to significantly affect intracellular K ϩ levels (Fig.  3A) . When only intracellular K ϩ data was analyzed, AsH 3 showed the more profound toxic effect compared to AsIII. Intracellular K ϩ was decreased by 50% with 10 M AsH 3 , 70% with 100 M and reached 88% with 1 mM AsH 3 (Fig.  3A) . Conversely, 100 M AsIII decreased intracellular K ϩ by only 20% and reached 77% with 1 mM AsIII (Fig. 3A) . Analysis of LDH leakage data showed similar toxicity patterns with both arsenicals. LDH leakage increased after incubation with both arsenicals at concentrations greater than 10 M and reached a plateau (close to 100%) at 100 M of either arsenical ( Fig. 3B) . Like the erythrocytes, these data suggested that AsH 3 affected a K ϩ transporter first, which was followed by damage to cell integrity. The effect on the K ϩ transporter may be related to a direct effect of AsH 3 . The effect on cell integrity may be related first to the formation of a reactive metabolite followed by AsIII formation from AsH 3 metabolism. The latter effect was supported by the finding that the direct effect of AsIII was related more to damage to cell membranes, which resulted in a loss of both K ϩ and LDH in a similar fashion. The effects of AsH 3 and AsIII on hepatocytes were time-and dose-dependent.
Rat Renal Cortical Epithelial Cells
Rat renal cortical epithelial cells were incubated with 1 mM of either arsenical for 1, 3, and 5 h (time response) and for 24 h with 10 -1000 M of AsH 3 or AsIII (dose response). Unlike the erythrocytes and hepatocytes, the renal cells were more susceptible to AsIII toxicity. Incubation with 1 mM AsH 3 for up to 5 h showed no effect on intracellular K ϩ or LDH release (Figs. 4A and 4B) . One mM AsIII, on the other hand, decreased intracellular K ϩ content by 20 and 46% at 3 and 5 h, respectively (Fig. 4A) , and significantly increased LDH release by 25 and 63% of total LDH at 3 and 5 h, respectively (Fig.  4B) . Incubation with either arsenical at various concentrations for 24 h showed similar intracellular K ϩ data. Intracellular K ϩ was only significantly affected with 1000 M AsH 3 , whereas 5 M AsIII was enough to significantly decrease K ϩ levels by 30% (Fig. 5A) . Intracellular K ϩ level was decreased up to 75% with 1000 M AsIII (Fig. 5A) . Unlike erythrocytes and hepatocytes, LDH release preceded K ϩ leakage in renal cortical epithelial cells exposed to AsH 3 for 24 h. Concentrations from 5 to 1000 M AsH 3 significantly increased LDH release, which reached 80% of total LDH at 1000 M AsH 3 (Fig. 5B) . AsH 3 concentrations up to 500 M had no effect on K ϩ levels, but the percent of total LDH leakage was increased by 60% (Figs. 5A and 5B). AsIII produced a more profound effect on LDH release than AsH 3 . Five M AsIII released 40% of the total LDH and 100 M was enough to produce 100% of total LDH release (Fig. 5B) . These data suggested that the K ϩ transporter was not the primary target of AsH 3 in the renal cortical epithelial cells. Thus, AsH 3 may not have a direct effect on the rat kidney. Cell integrity (LDH) was affected by low AsH 3 concentrations at 24 h. It was found that after 24-h exposure to AsH 3 , LDH started to leak, but the cell maintained ion homeostasis until this effort was overcome (at ϳ500 M AsH 3 ).
Arsine Oxidation to AsIII and As(V) by the Rat Liver and Kidney Homogenates
Tissue homogenates were prepared as described in Materials and Methods. Tissue homogenates or PBS (control) was incubated with 1 mM AsH 3 . AsH 3 was lost from incubation reactions at the same rate as control (PBS) (Fig. 6A) . The appearance of AsIII in liver homogenate or As(V) in both liver and kidney homogenates was low and was not significantly different from control (Figs. 6B and 6C ). The formation of AsIII in kidney homogenate was significantly greater than in liver homogenate or control (Fig. 6B) . These data indicated that the formation of these arsenicals (AsIII and AsV) from AsH 3 oxidation was low in blood and liver but was significantly greater for AsIII in the kidney homogenate.
DISCUSSION
In this study, we have investigated acute AsH 3 and AsIII toxicity in the rat using an in vitro system. The purpose was to determine whether the organ toxicities observed in the blood, liver, and kidney of humans were a direct effect of AsH 3 , or if conversion to another toxic arsenical, AsIII, was required for toxicity. Although AsIII and AsV have been found as metab- olites of AsH 3 , it is probable that other arsenic compounds such as As(0) are also formed. As(0) has not been analyzed but its presence in aqueous solution was indicated by a precipitate. We expected that comparing rat tissue preparations for their response to AsH 3 and AsIII would determine whether AsH 3 acts directly or after forming AsIII. We also expected to determine whether AsH 3 was acutely toxic to the kidney. We found that rat erythrocytes were very susceptible to AsH 3 toxicity and resistant to AsIII. In AsH 3 -treated erythrocytes, potassium leakage preceded LDH leakage. This finding was in agreement with Winski et al. (1997) who also reported significant potassium loss in AsH 3 -treated human erythrocytes at 15 min. They reported about 25 and 45% potassium loss in 15 and 30 min, respectively. Here we found an immediate 40% potassium loss that reached 65% by 5 min when rat erythrocytes were incubated to 0.5 mM AsH 3 , half the concentration used by Winski et al. (1997) . The results obtained here from rat erythrocytes were in agreement with Hatlelid et al. (1995) who also reported greater susceptibility of rat erythrocytes to AsH 3 toxicity compared to dog erythrocytes. This finding in dog erythrocytes made the Na-K-ATPase pump a less probable candidate for the AsH 3 target (dog erythrocytes lack this pump), as postulated by many other investigators. In addition, AsH 3 did not significantly alter ATP levels or inhibit the ATPase in human erythrocytes (Winski et al. 1997) . However, several potassium transport systems are present in erythrocytes of various species: Na,K-ATPase, Na,K,2Cl cotransport, K,Cl cotransport, a calcium activated K ϩ channel, and a residual (leak) K ϩ transporter (Ihrig et al. 1992) . Potassium loss in erythrocytes after AsH 3 exposure may be related to the AsH 3 effect on a different potassium transporter. Another possibility may be the formation of lipid peroxides and/or crosslinking of membrane thiols, which increase membrane permeability. Animal species differences to AsH 3 toxicity exist and the rat appeared to be the most susceptible species.
Rat primary hepatocytes were susceptible to both arsenic species. AsIII was more toxic than AsH 3 at the same time points studied. It is known that AsIII binds to important enzymes and cell membrane components producing toxicity. The AsH 3 effect on both K ϩ content and cell integrity in liver may be related first to the effect of unchanged AsH 3 and later to the formation of a reactive AsH 3 -metabolite (Fig. 7) . It is possible that AsH 3 escapes unchanged from blood and reaches the hepatocytes. The total circulation time in man is about 25 s (Levvy, 1947) , and the reaction between AsH 3 and human erythrocytes is not so rapid that it is impossible for part of the AsH 3 dissolved in plasma to escape and to be carried to organs such as the liver and kidney. Levvy (1947) also concluded that unchanged AsH 3 reaches the liver and kidney and hypothesized that arsenic found by other investigators in the tissues of dogs after chronic arsenic poisoning was derived from hemolyzed red blood corpuscles. Hatlelid et al. (1995) reported 44.5 and 55.6% of cellular arsenic cytosol-dissolved and membrane-associated, respectively, when rat red blood cells were incubated with 0.49 mM AsH 3 for 10 min. We determined low levels of AsIII and AsV formed from AsH 3 oxidation by the liver homogenate.
The effects of AsH 3 and AsIII were also determined on rat Rat tissue homogenates were prepared and dosed with arsine as described in Materials and Methods. Formed arsenicals were determined by the method of Winski and Carter (1995) . Values are mean Ϯ SD (n ϭ 3, *p Ͻ 0.05, **p Ͻ 0.01).
renal cortical epithelial cells. These cells, unlike erythrocytes and hepatocytes, were more susceptible to AsIII toxicity. A dose response for AsH 3 in this system showed that intracellular K ϩ was not significantly affected whereas LDH was released. On the other hand, AsIII was very toxic on both toxic parameters. It was discussed earlier that it is possible that unchanged AsH 3 reaches the kidney in combination with blood hemolysate containing AsH 3 products, possibly AsIII. The unchanged AsH 3 reaching the kidney would be rapidly oxidized to AsIII. It was showed here that AsH 3 is rapidly metabolized to AsIII by the kidney homogenate and later to AsV. It is also probable that AsIII was oxidized further to AsV.
The cause for the unique susceptibility of erythrocytes to AsH 3 is unknown, but may be related to the absence of nucleus and mitochondria or to the large amount of heme present. There exists considerable evidence indicating that AsH 3 reacts with hemoglobin (Hatlelid et al. 1996; Blair et al. 1990) causing oxidation and denaturation that may lead to toxicity. We postulate that a heme protein activates AsH 3 to a toxic intermediate. In the red blood cell, hemoglobin constitutes more than 90% of erythrocyte protein (Josephy, 1997; Whittam, 1964) and would represent the site with the highest formation of toxic intermediate and therefore toxicity. The absence of nucleus and mitochondria in the erythrocyte explains the lack of susceptibility to AsIII, an arsenic species that affects mitochondrial respiration and heme synthesis. In liver and kidney, heme proteins exist in the form of hemoglobins, myoglobins, cytochromes, catalases, and peroxidases. Unless tissues are perfused with solutions to remove blood, the major heme protein would be hemoglobin. In our study, we perfused both liver and kidney during the preparation of primary hepatocytes and renal cortical epithelial cells. In addition, an erythrocyte-lysing solution was used in the preparation of renal cortical epithelial cells and these cells were washed to clear any hemoglobin. Total heme proteins in unperfused and salineperfused liver are 7.37 and 2.53 g of heme protein/mg fresh weight, respectively (65.7% removed) (Morrison, 1965) . In unperfused and perfused kidney these heme proteins are 4.53 and 0.89 g heme protein/mg fresh weight, respectively (80.3% removed) (Morrison, 1965) . Cytochrome P450 is one of these hemoproteins that have the ability to reversibly bind oxygen, much like hemoglobin. The rat liver contains about 1.10 nmol P450/mg protein (Guengerich et al. 1982) . Cytochrome P450, in conjunction with total heme proteins, may make the liver susceptible to AsH 3 toxicity. Unlike the erythrocytes, in hepatocytes AsIII toxicity is manifested by decreasing mitochondrial respiration (Konings, 1972) and heme synthesis (Cebrian et al. 1988) . In kidney, renal cells also contain hemoprotein in the form of cytochrome P450. By comparison, rat kidney microsomes have about 0.15 nmol P450/mg protein (Burke and Orrenius, 1979) . This is only about 20% of the concentration in control rat-liver microsomes. Another heme protein in both liver and kidney is cytochrome b 5 whose concentration in kidney microsomes is 0.13 nmol/mg protein, which approximately equals the concentration of cytochrome P450 (Burke and Orrenius, 1979) . If heme in any form is sufficient to catalyze AsH 3 toxicity, susceptibility should correlate to heme content. The data support this correlation. AsH 3 was very toxic to erythrocytes, the cell type with the highest heme content. AsH 3 was also toxic to hepatocytes that contain the second highest content of hemeproteins (here as P450). Finally, AsH 3 was the least toxic to renal cells, the cell type with the least hemeproteins and cytochrome P450 content of the three tissues.
In conclusion, the toxic potency of AsH 3 was different for different organs in the Sprague-Dawley rat. Erythrocytes were very susceptible to AsH 3 toxicity. Liver was susceptible to both arsenic species and was the second most susceptible to AsH 3 toxicity, whereas kidney was the most susceptible to AsIII toxicity and the least susceptible to AsH 3 toxicity. The toxicity of AsH 3 resulted from a direct action and not because of its conversion to AsIII. We found that potassium loss is not necessary for LDH release to occur. Potassium loss may be a different toxic response from LDH-release response and may be caused by different arsenic species. A reaction between AsH 3 and hemoproteins may be important in forming a reactive compound.
FIG. 7.
Schematic diagram of the proposed mechanism for arsine metabolism and toxicity. The cell in the diagram represents a hepatocyte/renal cell. Unchanged arsine may be the responsible toxic species for the ion transport effect. Arsine gets into the cell and can react with hemoproteins (heme FeII) producing an unknown metabolite that is responsible for cell death. At the same time, arsine inside the cells is metabolized to AsIII, which produces toxicity to the mitochondria and, by depleting energy production, contributes to cell death.
